{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:59:30Z","timestamp":1781506770261,"version":"3.54.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T00:00:00Z","timestamp":1597104000000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neth Heart J"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>While the beneficial effects of secondary prevention of cardiovascular disease are undisputed, implementation remains challenging. A\u00a0gap between guideline-mandated risk factor targets and clinical reality was documented as early as the 1990s. To address this issue, research groups in the Netherlands have performed several major projects. These projects address innovative, multidisciplinary strategies to improve medication adherence and to stimulate healthy lifestyles, both in the setting of cardiac rehabilitation and at dedicated outpatient clinics. The findings of these projects have led to changes in prevention and rehabilitation guidelines.<\/jats:p>","DOI":"10.1007\/s12471-020-01450-w","type":"journal-article","created":{"date-parts":[[2020,8,11]],"date-time":"2020-08-11T14:04:55Z","timestamp":1597154695000},"page":"136-140","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The scientific basis for secondary prevention of coronary artery disease: recent contributions from the Netherlands"],"prefix":"10.1007","volume":"28","author":[{"given":"H. T.","family":"J\u00f8rstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Snaterse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"ter Hoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Sunamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Kemps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. J. M.","family":"Scholte op Reimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J. G.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,11]]},"reference":[{"key":"1450_CR1","doi-asserted-by":"crossref","unstructured":"Piepoli MF, Hoes AW, Agewall S, et\u00a0al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016;37:2315\u201381.","DOI":"10.1093\/eurheartj\/ehw106"},{"key":"1450_CR2","doi-asserted-by":"crossref","unstructured":"Eckel R, Jakicic J,\u00a0Ard J, et\u00a0al. 2013 AHA\/ACC Guideline on Lifestyle Management to Reduce Cardiovascular Risk. J\u00a0Am Coll Cardiol.\u00a02014;63(25 Part B):2960\u201384.","DOI":"10.1016\/j.jacc.2013.11.003"},{"key":"1450_CR3","unstructured":"Stone N,\u00a0Robinson J,\u00a0Lichtenstein A, et\u00a0al. 2013 ACC\/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults. J\u00a0Am Coll Cardiol.\u00a02014;63(25 Part B):2889\u2013934."},{"key":"1450_CR4","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1136\/heartjnl-2013-303640","volume":"99","author":"J Dorresteijn","year":"2013","unstructured":"Dorresteijn\u00a0J, Visseren\u00a0F, Wassink\u00a0A, et\u00a0al. SMART Study Group. Development and validation of a prediction rule for recurrent vascular events based on a cohort study of patients with arterial disease. the SMART risk score. Heart. 2013;99:866\u201372.","journal-title":"Heart"},{"key":"1450_CR5","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s00392-016-1023-8","volume":"106","author":"M Stam-Slob","year":"2017","unstructured":"Stam-Slob\u00a0M, Visseren\u00a0F, Jukema\u00a0J, et al. Personalized absolute benefit of statin treatment for primary or secondary prevention of vascular disease in individual elderly patients. Clin Res Cardiol. 2017;106:58\u201368.","journal-title":"Clin Res Cardiol"},{"key":"1450_CR6","doi-asserted-by":"crossref","first-page":"e009217","DOI":"10.1161\/JAHA.118.009217","volume":"21;7","author":"L Kaasenbrood","year":"2018","unstructured":"Kaasenbrood\u00a0L, Bhatt\u00a0DL, Dorresteijn\u00a0J, et al. Estimated Life Expectancy Without Recurrent Cardiovascular Events in Patients With Vascular Disease: The SMART-REACH Model. J\u00a0Am Heart Assoc. 2018;21;7:e9217.","journal-title":"J Am Heart Assoc"},{"key":"1450_CR7","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1093\/eurheartj\/ehy839","volume":"40","author":"GFN Berkelmans","year":"2019","unstructured":"Berkelmans\u00a0GFN, Gudbj\u00f6rnsdottir\u00a0S, Visseren\u00a0FLJ, et al. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500\u00a0000 patients with Type 2 diabetes mellitus. Eur Heart\u00a0J. 2019;40:2899\u2013906.","journal-title":"Eur Heart J"},{"key":"1450_CR8","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1016\/S0140-6736(08)60868-5","volume":"371","author":"DA Wood","year":"2008","unstructured":"Wood\u00a0DA, Kotseva\u00a0K, Connolly\u00a0S, et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a\u00a0paired, cluster-randomised controlled trial. Lancet. 2008;371:1999\u20132012.","journal-title":"Lancet"},{"key":"1450_CR9","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1136\/heartjnl-2013-303989","volume":"99","author":"HT J\u00f8rstad","year":"2013","unstructured":"J\u00f8rstad\u00a0HT, von Birgelen\u00a0C, Alings\u00a0AM, et al. Effect of a\u00a0nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart. 2013;99:1421\u201330.","journal-title":"Heart"},{"issue":"2","key":"1450_CR10","doi-asserted-by":"publisher","first-page":"e000607","DOI":"10.1136\/openhrt-2017-000607","volume":"4","author":"M Snaterse","year":"2017","unstructured":"Snaterse M, J\u00f8rstad HT, Heiligenberg M, et al. Nurse-coordinated care improves the achievement of LDL-cholesterol targets through more intensive medication titration. Open Heart. 2017;4(2):e000607.","journal-title":"Open Heart"},{"key":"1450_CR11","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1186\/s12872-016-0321-4","volume":"16","author":"HT J\u00f8rstad","year":"2016","unstructured":"J\u00f8rstad\u00a0HT, Minneboo\u00a0M, Helmes\u00a0HJ, et al. Effects of a\u00a0Nurse-Coordinated Prevention Programme on Health-Related Quality of Life and Depression in Patients with an Acute Coronary Syndrome: Results from the RESPONSE Randomised Controlled Trial. BMC Cardiovasc Disord. 2016;16:144.","journal-title":"BMC Cardiovasc Disord"},{"key":"1450_CR12","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jacc.2017.05.041","volume":"70","author":"M Minneboo","year":"2017","unstructured":"Minneboo\u00a0M, Lachman\u00a0S, Snaterse\u00a0M, et al. Community-Based Lifestyle Intervention in Patients With Coronary Artery Disease: The RESPONSE 2 Trial. J\u00a0Am Coll Cardiol. 2017;70:318\u201327.","journal-title":"J Am Coll Cardiol"},{"key":"1450_CR13","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2522\/ptj.20130509","volume":"95","author":"N ter Hoeve","year":"2015","unstructured":"ter Hoeve\u00a0N, Huisstede\u00a0B, Stam\u00a0H, et\u00a0al. Does cardiac rehabilitation after an acute cardiac syndrome lead to changes in physical activity habits? Systematic review. Phys Ther. 2015;95:167\u201379.","journal-title":"Phys Ther"},{"key":"1450_CR14","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.apmr.2017.05.008","volume":"98","author":"N Ter Hoeve","year":"2017","unstructured":"Ter Hoeve\u00a0N, Sunamura\u00a0M, van Geffen\u00a0M, et\u00a0al. Changes in Physical Activity and Sedentary Behavior During Cardiac Rehabilitation. Arch Phys Med Rehabil. 2017;98:2378\u201384.","journal-title":"Arch Phys Med Rehabil"},{"key":"1450_CR15","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1136\/heartjnl-2017-311681","volume":"104","author":"M Sunamura","year":"2018","unstructured":"Sunamura\u00a0M, ter Hoeve\u00a0N, van den Berg-Emons\u00a0RJG, et al. Randomised controlled trial of two advanced and extended cardiac rehabilitation programmes. Heart. 2018;104:430\u20137.","journal-title":"Heart"},{"key":"1450_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.ijcard.2017.12.015","volume":"255","author":"N Ter Hoeve","year":"2018","unstructured":"Ter Hoeve\u00a0N, Sunamura\u00a0M, Stam\u00a0H, et\u00a0al. Effects of two behavioral cardiac rehabilitation interventions on physical activity: A randomized controlled trial. Int J Cardiol. 2018;255:221\u20138.","journal-title":"Int J Cardiol"},{"key":"1450_CR17","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/0269215519842216","volume":"33","author":"N Ter Hoeve","year":"2019","unstructured":"Ter Hoeve\u00a0N, Sunamura\u00a0M, Stam\u00a0H, et\u00a0al. A secondary analysis of data from the OPTICARE randomized controlled trial investigating the effects of extended cardiac rehabilitation on functional capacity, fatigue, and participation in society. Clin Rehabil. 2019;33:1355\u201366.","journal-title":"Clin Rehabil"},{"key":"1450_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1177\/2047487316679905","volume":"24","author":"KE Minges","year":"2017","unstructured":"Minges\u00a0KE, Strait\u00a0KM, Owen\u00a0N, et\u00a0al. Gender differences in physical activity following acute myocardial infarction in adults: A prospective, observational study. Eur J Prev Cardiol. 2017;24:192\u2013203.","journal-title":"Eur J Prev Cardiol"},{"key":"1450_CR19","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1038\/oby.2012.119","volume":"20","author":"BJ Martin","year":"2012","unstructured":"Martin\u00a0BJ, Aggarwal\u00a0SG, Stone\u00a0JA, et al. Obesity negatively impacts aerobic capacity improvements both acutely and 1\u2011year following cardiac rehabilitation. Obes (silver Spring). 2012;20:2377\u201383.","journal-title":"Obes (silver Spring)"},{"key":"1450_CR20","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1177\/2047487318825350","volume":"26","author":"K Kotseva","year":"2019","unstructured":"Kotseva\u00a0K, De Backer\u00a0G, De Bacquer\u00a0D, et al. EUROASPIRE Investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries. Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry. Eur J Prev Cardiol. 2019;26:824\u201335.","journal-title":"Eur J Prev Cardiol"},{"key":"1450_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ijcard.2018.01.064","volume":"258","author":"M Snaterse","year":"2018","unstructured":"Snaterse\u00a0M, Deckers\u00a0JW, Lenzen\u00a0M, et\u00a0al. for the EUROASPIRE investigators. Smoking cessation in European patients with coronary heart disease. Results from the EUROASPIRE IV survey. A registry from the European Society of Cardiology. Int J Cardiol. 2018;258:1\u20136.","journal-title":"Int J Cardiol"},{"key":"1450_CR22","doi-asserted-by":"crossref","unstructured":"Snaterse M, Scholte op Reimer WJM, Dobber J, et\u00a0al. Smoking cessation after an acute coronary syndrome: immediate quitters are successful quitters. Neth Heart J. 2015;23:600\u20137.","DOI":"10.1007\/s12471-015-0755-9"},{"key":"1450_CR23","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1177\/1474515118795722","volume":"18","author":"M Snaterse","year":"2019","unstructured":"Snaterse\u00a0M, J\u00f8rstad\u00a0HT, Minneboo\u00a0M, et al. Nurse-coordinated referral to a\u00a0community-based smoking cessation programme in patients with coronary artery disease: results from the RESPONSE\u20112 study. Eur J Cardiovasc Nursing. 2019;18:113\u201321.","journal-title":"Eur J Cardiovasc Nursing"},{"key":"1450_CR24","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1177\/1357633X14562732","volume":"21","author":"I Frederix","year":"2015","unstructured":"Frederix\u00a0I, Vanhees\u00a0L, Dendale\u00a0P, et\u00a0al. A review of telerehabilitation for cardiac patients. J\u00a0Telemed Telecare. 2015;21:45\u201353.","journal-title":"J Telemed Telecare"},{"key":"1450_CR25","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1136\/heartjnl-2015-308966","volume":"102","author":"JC Rawstorn","year":"2016","unstructured":"Rawstorn\u00a0JC, Gant\u00a0N, Direito\u00a0A, et al. Telehealth exercise-based cardiac rehabilitation: a\u00a0systematic review and meta-analysis. Heart. 2016;102:1183\u201392.","journal-title":"Heart"},{"key":"1450_CR26","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1471-2261-13-82","volume":"13","author":"JJ Kraal","year":"2013","unstructured":"Kraal\u00a0JJ, Peek\u00a0N, Marle\u00a0MEA\u2011V, et al. Effects and costs of home-based training with telemonitoring guidance in low to moderate risk patients entering cardiac rehabilitation: The FIT@Home study. BMC Cardiovasc Disord. 2013;13:82.","journal-title":"BMC Cardiovasc Disord"},{"key":"1450_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1177\/2047487314535076","volume":"22","author":"R Maddison","year":"2015","unstructured":"Maddison\u00a0R, Pfaeffli\u00a0L, Whittaker\u00a0R, et\u00a0al. A mobile phone intervention increases physical activity in people with cardiovascular disease: Results from the HEART randomized controlled trial. Eur J Prev Cardiol. 2015;22:701\u20139.","journal-title":"Eur J Prev Cardiol"},{"key":"1450_CR28","doi-asserted-by":"crossref","unstructured":"Snoek JA, Meindersma EP, Prins LF, et\u00a0al. The sustained effects of extending cardiac rehabilitation with a\u00a0six-month telemonitoring and telecoaching programme on fitness, quality of life, cardiovascular risk factors and care utilisation in CAD patients: The TeleCaRe study. J Telemed Telecare. 2019;1357633X19885793. Epub ahead of print.","DOI":"10.1177\/1357633X19885793"},{"key":"1450_CR29","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1177\/2047487317710803","volume":"24","author":"JJ Kraal","year":"2017","unstructured":"Kraal\u00a0JJ, Van den Akker-Van Marle\u00a0ME, Abu-Hanna\u00a0A, et al. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study. Eur J Prev Cardiol. 2017;24:1260\u201373.","journal-title":"Eur J Prev Cardiol"},{"issue":"1","key":"1450_CR30","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12872-017-0477-6","volume":"17","author":"RWM Brouwers","year":"2017","unstructured":"Brouwers RWM, Kraal JJ, Traa SCJ, et al. Effects of cardiac telerehabilitation in patients with coronary artery disease using a\u00a0personalised patient-centred web application: Protocol for the SmartCare-CAD randomised controlled trial. BMC Cardiovasc Disord. 2017;17(1):46.","journal-title":"BMC Cardiovasc Disord"}],"container-title":["Netherlands Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01450-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12471-020-01450-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12471-020-01450-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,6]],"date-time":"2022-11-06T14:45:23Z","timestamp":1667745923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12471-020-01450-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":30,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["1450"],"URL":"https:\/\/doi.org\/10.1007\/s12471-020-01450-w","relation":{},"ISSN":["1568-5888","1876-6250"],"issn-type":[{"value":"1568-5888","type":"print"},{"value":"1876-6250","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"11 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.T.\u00a0J\u00f8rstad, M.\u00a0Snaterse, N.\u00a0ter Hoeve, M.\u00a0Sunamura, R.\u00a0Brouwers, H.\u00a0Kemps, W.J.M.\u00a0Scholte op Reimer and R.J.G.\u00a0Peters declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}